[{"Assets_0_FY_USD":14275109000.0,"CommonStockSharesOutstanding_0_FY_shares":222954175.0,"EarningsPerShareBasic_1_FY_USD":-14.98,"EarningsPerShareBasic_4_FY_USD":-15.03,"EarningsPerShareDiluted_1_FY_USD":-14.98,"EarningsPerShareDiluted_4_FY_USD":-15.03,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":524439000.0,"NetIncomeLoss_1_FY_USD":-3337856000.0,"NetIncomeLoss_4_FY_USD":-3347066000.0,"StockholdersEquity_0_FY_USD":2701589000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":222870000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":222651000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":222870000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":222651000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170301"}]